Cargando…

Home-Based Monitoring of Pulmonary Function in Patients with Duchenne Muscular Dystroph

BACKGROUND: Loss of pulmonary function is a main cause of early morbidity and mortality in patients with Duchenne muscular dystrophy (DMD). Standard of care guidelines recommend regular assessment of pulmonary function by hospital-based spirometry to detect onset and monitor progression of pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buyse, Gunnar M., Rummey, Christian, Meier, Thomas, Leinonen, Mika, Voit, Thomas, McDonald, Craig M., Mayer, Oscar H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218142/ https://www.ncbi.nlm.nih.gov/pubmed/30282375 http://dx.doi.org/10.3233/JND-180338

Ejemplares similares

Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy
por: Mayer, Oscar H., et al.
Publicado: (2017)

Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy
por: Buyse, Gunnar M., et al.
Publicado: (2016)

Characterization of pulmonary function in Duchenne Muscular Dystrophy
por: Mayer, O.H., et al.
Publicado: (2015)

Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy
por: Biggar, W. Douglas, et al.
Publicado: (2022)

CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype
por: de Zélicourt, Antoine, et al.
Publicado: (2022)

Macroglossia and less advanced dystrophic change in the tongue muscle of the Duchenne muscular dystrophy rat
por: Yamanouchi, Keitaro, et al.
Publicado: (2022)

Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy
por: Alves, Francesca M., et al.
Publicado: (2022)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

Myostatin Is a Quantifiable Biomarker for Monitoring Pharmaco-gene Therapy in Duchenne Muscular Dystrophy
por: Mariot, Virginie, et al.
Publicado: (2020)

Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy
por: Betts, Corinne A., et al.
Publicado: (2015)

Placebo‐controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy
por: McDonald, Craig M., et al.
Publicado: (2018)

Suitability of external controls for drug evaluation in Duchenne muscular dystrophy
por: Goemans, Nathalie, et al.
Publicado: (2020)

Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
por: Amor, Fatima, et al.
Publicado: (2021)

Muscle Pathology in Dystrophic Rats and Zebrafish Is Unresponsive to Taurine Treatment, Compared to the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Terrill, Jessica R., et al.
Publicado: (2023)

Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2022)

Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular Dystrophy
por: Fang, Yuan, et al.
Publicado: (2023)

Medical management of muscle weakness in Duchenne muscular dystrophy
por: Rivera, Sarah R., et al.
Publicado: (2020)

Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy
por: Clemens, Paula R., et al.
Publicado: (2022)

Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
por: Larkindale, Jane, et al.
Publicado: (2017)

Functional and Clinical Outcomes Associated with Steroid Treatment among Non-ambulatory Patients with Duchenne Muscular Dystrophy(1)
por: McDonald, Craig M., et al.
Publicado: (2023)

A dystrophic Duchenne mouse model for testing human antisense oligonucleotides
por: Veltrop, Marcel, et al.
Publicado: (2018)

Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy
por: Barthélémy, Inès, et al.
Publicado: (2014)

Cardiac function associated with home ventilator care in Duchenne muscular dystrophy
por: Lee, Sangheun, et al.
Publicado: (2018)

Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy
por: Ricotti, Valeria, et al.
Publicado: (2023)

Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy
por: Lo Cascio, Christian M., et al.
Publicado: (2016)

Influence of β(2) adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy
por: Kelley, Eli F., et al.
Publicado: (2019)

A Movement Monitor Based on Magneto-Inertial Sensors for Non-Ambulant Patients with Duchenne Muscular Dystrophy: A Pilot Study in Controlled Environment
por: Le Moing, Anne-Gaëlle, et al.
Publicado: (2016)

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2019)

Dystrophic cardiomyopathy: role of the cardiac myofilaments
por: George, Thomas G., et al.
Publicado: (2023)

Dystrophic muscle distribution in late-stage muscular dystrophy
por: Pilato, Celeste Michelle, et al.
Publicado: (2020)

Myocardial strain imaging in Duchenne muscular dystrophy
por: Earl, Conner C., et al.
Publicado: (2022)

Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
por: Goemans, Nathalie M., et al.
Publicado: (2016)

A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy
por: Hakim, Chady H., et al.
Publicado: (2017)

Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences
por: Henricson, Erik, et al.
Publicado: (2012)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy
por: Khan, Navid, et al.
Publicado: (2019)

Living with severe physical impairment, Duchenne's muscular dystrophy and home mechanical ventilation
por: Dreyer, Pia S., et al.
Publicado: (2010)

Corrigendum: Cardiac function associated with home ventilator care in Duchenne muscular dystrophy
por: Lee, Sangheun, et al.
Publicado: (2019)

Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8sik3m9j0dhidqvj0vgqapmi18